JAK Inhibition as a New Treatment Strategy for Patients with COVID-19
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
After the advent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the outbreak of coronavirus disease 2019 (COVID-19) commenced across the world. Understanding the Immunopathogenesis of COVID-19 is essential for interrupting viral infectivity and preventing aberrant immune responses before a vaccine can be developed. In this review,...
Alternative Titles
Full title
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_citationtrail_10_1159_000508247
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_1159_000508247
Other Identifiers
ISSN
1018-2438
E-ISSN
1423-0097
DOI
10.1159/000508247
